846541-71-7 Usage
Uses
Used in Pharmaceutical Industry:
5-Chloro-4,6-dihydroxynicotinic acid ethyl ester is used as a key intermediate in the synthesis of various drugs. Its unique structure allows for the development of new compounds with potential therapeutic benefits, contributing to the advancement of medicine and healthcare.
Used in Agrochemical Industry:
In the agrochemical sector, 5-Chloro-4,6-dihydroxynicotinic acid ethyl ester serves as an essential building block in the production of pesticides. Its incorporation into these compounds helps enhance their effectiveness in protecting crops and managing pests, thereby supporting agricultural productivity and food security.
Used as a Research Compound:
5-Chloro-4,6-dihydroxynicotinic acid ethyl ester is also utilized in research and development, where it aids scientists in understanding the properties and behavior of pyridine carboxylic acids. Its role in the synthesis of new compounds and the exploration of their potential applications further expands the horizons of scientific knowledge and innovation.
Check Digit Verification of cas no
The CAS Registry Mumber 846541-71-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,6,5,4 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 846541-71:
(8*8)+(7*4)+(6*6)+(5*5)+(4*4)+(3*1)+(2*7)+(1*1)=187
187 % 10 = 7
So 846541-71-7 is a valid CAS Registry Number.
InChI:InChI=1/C8H8ClNO4/c1-2-14-8(13)4-3-10-7(12)5(9)6(4)11/h3H,2H2,1H3,(H2,10,11,12)
846541-71-7Relevant articles and documents
Potent and selective mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors. 1. 4-(4-bromo-2-fluorophenylamino)-1-methylpyridin-2(1h)-ones
Wallace, Eli M.,Lyssikatos, Joseph,Blake, James F.,Seo, Jeongbeob,Yang, Hong Woon,Yeh, Tammie C.,Perrier, Michele,Jarski, Heidi,Marsh, Vivienne,Poch, Gregory,Livingston, Michelle Goyette,Otten, Jennifer,Hingorani, Gary,Woessner, Rich,Lee, Patrice,Winkler, James,Koch, Kevin
, p. 441 - 444 (2007/10/03)
The role of MEK 1,2 in cancer tumorgenesis has been clearly demonstrated preclinically, and two selective inhibitors are currently undergoing clinical evaluation to determine their role in the human disease. We have discovered 4-(4-bromo-2-fluorophenylamino)-1-methylpyridin-2(1H)-ones as a new class of ATP noncompetitive MEK inhibitors. These inhibitors exhibit excellent cellular potency and good pharmacokinetic properties and have demonstrated the ability to inhibit ERK phosphorylation in HT-29 tumors from mouse xenograft studies.